 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
4 terms
|
 |
|
Biological process
|
immune response
|
3 terms
|
 |
|
Biochemical function
|
protein binding
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
FEBS Lett
349:79-83
(1994)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of human interleukin-1 receptor antagonist protein.
|
|
B.J.Stockman,
T.A.Scahill,
N.A.Strakalaitis,
D.P.Brunner,
A.W.Yem,
M.R.Deibel.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Interleukin-1 receptor antagonist protein (IRAP) is a naturally occurring
inhibitor of the interleukin-1 receptor. In contrast to IL-1 beta, IRAP binds to
the IL-1 receptor but does not elicit a physiological response. We have
determined the solution structure of IRAP using NMR spectroscopy. While the
overall topology of the two 153-residue proteins is quite similar, functionally
critical differences exist concerning the residues of the linear amino acid
sequence that constitute structurally homologous regions in the two proteins.
Structurally homologous residues important for IL-1 receptor binding are
conserved between IRAP and IL-1 beta. By contrast, structurally homologous
residues critical for receptor activation are not conserved between the two
proteins.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Z.Q.Wen,
X.Cao,
and
A.Vance
(2008).
Conformation and side chains environments of recombinant human interleukin-1 receptor antagonist (rh-IL-1ra) probed by raman, raman optical activity, and UV-resonance Raman spectroscopy.
|
| |
J Pharm Sci, 97,
2228-2241.
|
 |
|
|
|
|
 |
W.P.Arend,
M.Malyak,
C.J.Guthridge,
and
C.Gabay
(1998).
Interleukin-1 receptor antagonist: role in biology.
|
| |
Annu Rev Immunol, 16,
27-55.
|
 |
|
|
|
|
 |
S.A.Greenfeder,
T.Varnell,
G.Powers,
K.Lombard-Gillooly,
D.Shuster,
K.W.McIntyre,
D.E.Ryan,
W.Levin,
V.Madison,
and
G.Ju
(1995).
Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity.
|
| |
J Biol Chem, 270,
22460-22466.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|